Clinical and Experimental Hepatology

Abstract

1/2018 vol. 4
Original paper

The epidemiology of hepatocellular cancer in Poland

Dariusz Wasiak
,
Jacek Pliszczyński
,
Beata Łągiewska
,
Maurycy Jonas
,
Mariusz Panczyk
,
Piotr Małkowski
,
Wojciech Lisik
,
Maciej Kosieradzki
Clin Exp HEPATOL 2018; 4, 1: 13-27
DOI: https://doi.org/10.5114/ceh.2018.73669
Online publish date: 2018/02/09
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

This article summarize the available data on hepatocellular carcinoma (HCC) epidemiology in Poland. Data regarding the HCC incidence rate are divergent. Statistical data presented by NFZ appear more credible in that matter than data published by the Polish Oncology Center (POC).

Material and methods

The analysis included data from the Polish Bibliography Database (GBL), the Polish National Health Fund Institution (NFZ), the scientific paper “Malignant neoplasms in Poland” issued by POC and the central liver transplant registry maintained by the Polish transplant coordinating center “Poltransplant” (2010-2015).

Results

Data regarding the HCC incidence rate are divergent. Statistical data presented by NFZ appear more credible in that matter than data published by POC.

Conclusions

The occurrence of HCC in Poland is at the average European level and is similarly rising. The inci­dence rate is underestimated. It is due to faulty epidemiology data collection techniques. The highest risk group comprises men over the age of 50 with concomitant liver cirrhosis. The most common HCC etiology is HCV infection.

Keywords

liver transplantation, hepatocellular carcinoma, chronic liver disease

Share
Coverage in
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications